Plain-English translation of NCT07587099 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After you have a blocked heart artery opened using a special drug-coated balloon (without a stent), you normally take two blood clot-preventing medicines together. This trial is testing whether taking just one of these medicines—a drug called a P2Y12 inhibitor—works just as well and might be safer. The study will compare this single medication approach to the standard two-medicine approach in patients with stable heart disease.
Taking two blood clot medicines together can increase bleeding risk and cost. Researchers want to know if one medicine is enough to keep the artery open and prevent complications when using this newer balloon treatment, which might mean less risk for some patients.
You likely qualify if…
You likely don't qualify if…
After your balloon procedure, you will be randomly assigned to take either one or two blood clot-preventing medicines for a period of time. You will have follow-up visits to check how you are doing, monitor for any side effects or bleeding, and make sure your artery stays open. The study involves about 2,170 patients being enrolled across multiple hospitals to gather enough information to fairly compare the two treatment approaches.
AI-generated summary from trial data · Sep 1, 2026 · Not medical advice
China